TABLE OF CONTENTS INTRODUCTION 2

First Page		Document Content
Date: 2015-06-19 09:17:18 Medicine Clinical medicine Immunology Immunosuppressants Monoclonal antibodies Biotechnology Immune system TNF inhibitor Infliximab Adalimumab Disease-modifying antirheumatic drug Etanercept		TABLE OF CONTENTS INTRODUCTION 2 Add to Reading List Source URL: www.abirisk.eu Download Document from Source Website File Size: 435,49 KB Share Document on Facebook

	UCB Presents Latest Research from Immunology Portfolio at American College of Rheumatology Annual Meeting Data presentations include:  Positive results from Period 1 of the C-EARLY™ Phase 3 study of CIMZIA® (certol DocID: 1rakB - View Document
	JUNE 2015 TABLE OF CONTENTS INTRODUCTION DocID: 1qDC6 - View Document
	TABLE OF CONTENTS INTRODUCTION 2 DocID: 1qs3R - View Document
	TABLE OF CONTENTS INTRODUCTION 2 DocID: 1qius - View Document
	FEBRUARY 2015 TABLE OF CONTENTS INTRODUCTION DocID: 1qcKs - View Document